Condition
Microbial Composition
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Enrolling By Invitation1
Completed1
Withdrawn1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07843017Phase 2Not Yet Recruiting
Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia
NCT07585474Not ApplicableEnrolling By InvitationPrimary
Gut Microbiome Response to Long-Haul Travel in Elite Football Players
NCT03731702WithdrawnPrimary
Optimization of Collection Methods for Studies of the Human Microbiota
NCT02743195Not ApplicableCompleted
Polyphenol/Prebiotic Blend Effects on GI Health and Microbial Composition
Showing all 4 trials